A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
A newly approved Chinese drug for Alzheimer’s will start clinical trials in Europe and the US next year as the country’s first novel therapy for the incurable disease seeks global legitimacy.
Mon, 30 Dec, 2019
Thursday, January 27, 2022 - 7:00 AM
Wednesday, January 26, 2022 - 1:00 PM
Wednesday, January 26, 2022 - 8:00 PM